They say the eyes are the window to the soul, but a newly launched company is hoping they can also shed some light on early signs of disease.
The Russian Direct Investment Fund, and global pharmaceutical company Wockhardt Ltd have partnered to produce and supply Sputnik V and Sputnik Light covid-19 vaccines. The agreement was reached under the aegis of Enso Healthcare, RDIF's coordination partner for sourcing Sputnik V vaccines in India.
Today, Aegis Sciences Corporation launched TestingWorks! to help keep schools open during the COVID-19 pandemic through pooled testing. This testing program was designed to be simple for schools to use while reducing costs and increasing access to testing.
A participant receives a dose marking the start of Phase I trials for Aegis Life/Entos Pharmaceuticals COVID-19 DNA vaccine, Covigenix VAX-001. (Canadian Center for Vaccinology, IWK Health Centre, Nova Scotia).